A prospective, randomized, controlled trial comparing radiographic and clinical outcomes between stand-alone lateral interbody lumbar fusion with either silicate …

L Pimenta, L Marchi, L Oliveira… - … Surgery Part A …, 2013 - thieme-connect.com
Object Iliac crest autograft has traditionally been considered the gold standard for lumbar
spine fusion, though it is not without drawbacks related to harvesting site pain and other …

Fusion rates of lateral lumbar interbody fusion using recombinant human bone morphogenetic protein-2

AA Nourian, J Harrington, PA Pulido… - Global Spine …, 2019 - journals.sagepub.com
Study Design: Retrospective observational case series. Objectives: Lateral lumbar interbody
fusion (LLIF) has been widely performed with recombinant human bone morphogenetic …

Comparison of the use of rhBMP-7 versus iliac crest autograft in single-level lumbar fusion: a meta-analysis of randomized controlled trials

F Ye, Z Zeng, J Wang, H Liu, H Wang… - Journal of Bone and …, 2018 - Springer
The aim of this study was to evaluate the safety and clinical effectiveness of rhBMP-7 (or
osteogenic protein-1) versus that of autogenous iliac crest bone graft (ICBG) in single-level …

Posterior lumbar interbody fusion using rhBMP-2

HJ Meisel, M Schnöring, C Hohaus, Y Minkus… - European Spine …, 2008 - Springer
The use of biological technologies for the treatment of degenerative spinal diseases has
undergone rapid clinical and scientific development. BMP strategies have gained wide …

Clinical outcomes and fusion success at 2 years of single-level instrumented posterolateral fusions with recombinant human bone morphogenetic protein-2 …

JR Dimar, SD Glassman, KJ Burkus, LY Carreon - 2006 - journals.lww.com
Study Design. This is a prospective, randomized study comparing iliac crest bone graft to
bone morphogenetic protein (BMP)/compression resistant matrix in instrumented …

[PDF][PDF] The use of rh-BMP2 in standalone eXtreme Lateral Interbody Fusion (XLIF®): clinical and radiological results after 24 months follow-up

L Pimenta - World Spinal Column J, 2010 - researchgate.net
Study Design. Prospective, nonrandomized, nonblinded study to evaluate the clinical and
radiological results of the use of rh-BMP2 in patients that underwent single level XLIF …

Two-year fusion and clinical outcomes in 224 patients treated with a single-level instrumented posterolateral fusion with iliac crest bone graft

JR Dimar II, SD Glassman, JK Burkus, PW Pryor… - The Spine Journal, 2009 - Elsevier
BACKGROUND CONTEXT: Reported fusion rates for spine fusions using iliac crest bone
graft (ICBG) vary between 40% and 100% because of different fusion techniques, patient …

Posterior lumbar interbody fusion using recombinant human bone morphogenetic protein type 2 with cylindrical interbody cages

RW Haid Jr, CL Branch Jr, JT Alexander, JK Burkus - The Spine Journal, 2004 - Elsevier
BACKGROUND CONTEXT: In a large series of human patients undergoing open anterior
lumbar interbody fusion with a tapered titanium fusion cage, recombinant human bone …

Efficacy of autologous iliac crest bone graft and bone morphogenetic proteins for posterolateral fusion of lumbar spine: a meta-analysis of the results

C Papakostidis, G Kontakis, M Bhandari… - Spine, 2008 - journals.lww.com
Study Design. Meta analysis of randomized control trials. Objective. To evaluate the
radiographic and clinical effectiveness of bone morphogenetic proteins (BMPs) within the …

Prospective, randomized, controlled trial of silicate-substituted calcium phosphate versus rhBMP-2 in a minimally invasive transforaminal lumbar interbody fusion

SV Nandyala, A Marquez-Lara, SJ Fineberg, M Pelton… - 2014 - journals.lww.com
Study Design. Prospective, randomized, controlled trial. Objective. To compare arthrodesis
rates between patients undergoing a primary single-level minimally invasive transforaminal …